Invesco Ltd. Arcutis Biotherapeutics, Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 99,703 shares of ARQT stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,703

Previous 1,328,954 92.5%

Holding current value

$1.47 Million

Previous $20.8 Million 93.28%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$12.59 - $16.6 $15.5 Million - $20.4 Million	-1,229,251 Reduced 92.5%	99,703 $1.4 Million
Q1 2025 May 12, 2025	BUY	$11.4 - $17.29 $2.31 Million - $3.5 Million	202,286 Added 17.95%	1,328,954 $20.8 Million
Q4 2024 Feb 13, 2025	BUY	$8.31 - $14.99 $1.56 Million - $2.82 Million	188,184 Added 20.05%	1,126,668 $15.7 Million
Q3 2024 Nov 12, 2024	BUY	$8.32 - $11.0 $7,404 - $9,790	890 Added 0.09%	938,484 $8.73 Million
Q2 2024 Aug 13, 2024	BUY	$7.24 - $12.53 $472,410 - $817,582	65,250 Added 7.48%	937,594 $8.72 Million
Q1 2024 May 14, 2024	BUY	$3.25 - $11.77 $2.75 Million - $9.97 Million	847,208 Added 3370.5%	872,344 $8.64 Million
Q4 2023 Feb 12, 2024	BUY	$1.84 - $4.82 $115 - $303	63 Added 0.25%	25,136 $81,000
Q3 2023 Nov 13, 2023	SELL	$5.31 - $10.98 $1,306 - $2,701	-246 Reduced 0.97%	25,073 $133,000
Q2 2023 Aug 11, 2023	BUY	$7.51 - $15.0 $9,680 - $19,335	1,289 Added 5.36%	25,319 $241,000
Q1 2023 May 12, 2023	BUY	$10.23 - $17.14 $73,604 - $123,322	7,195 Added 42.74%	24,030 $264,000
Q4 2022 Feb 13, 2023	SELL	$13.96 - $20.4 $24,932 - $36,434	-1,786 Reduced 9.59%	16,835 $249,000
Q3 2022 Nov 14, 2022	SELL	$17.85 - $26.95 $3.4 Million - $5.14 Million	-190,554 Reduced 91.1%	18,621 $356,000
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $3.23 Million - $4.39 Million	197,916 Added 1757.85%	209,175 $4.46 Million
Q1 2022 May 16, 2022	BUY	$14.38 - $22.79 $2,861 - $4,535	199 Added 1.8%	11,259 $217,000
Q4 2021 Feb 14, 2022	SELL	$14.98 - $25.5 $30,768 - $52,377	-2,054 Reduced 15.66%	11,060 $229,000
Q3 2021 Nov 15, 2021	BUY	$19.28 - $27.1 $19,839 - $27,885	1,029 Added 8.51%	13,114 $314,000
Q2 2021 Aug 17, 2021	BUY	$24.42 - $34.75 $295,115 - $419,953	12,085 New	12,085 $331,000

Others Institutions Holding ARQT

# of Institutions

240

Shares Held

129M

Call Options Held

407K

Put Options Held

216K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $887M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account